Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Non Operating Income (2018 - 2025)

TransMedics has reported Non Operating Income over the past 8 years, most recently at $360000.0 for Q4 2025.

  • Quarterly results put Non Operating Income at $360000.0 for Q4 2025, up 121.75% from a year ago — trailing twelve months through Dec 2025 was -$1.1 million (up 38.17% YoY), and the annual figure for FY2025 was -$1.1 million, up 38.17%.
  • Non Operating Income for Q4 2025 was $360000.0 at TransMedics, up from -$269000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for TMDX hit a ceiling of $1.4 million in Q3 2023 and a floor of -$4.2 million in Q4 2021.
  • Median Non Operating Income over the past 5 years was -$419500.0 (2021), compared with a mean of -$606950.0.
  • Biggest five-year swings in Non Operating Income: skyrocketed 230.67% in 2023 and later tumbled 2639.29% in 2025.
  • TransMedics' Non Operating Income stood at -$4.2 million in 2021, then soared by 37.4% to -$2.6 million in 2022, then skyrocketed by 147.71% to $1.3 million in 2023, then plummeted by 231.35% to -$1.7 million in 2024, then soared by 121.75% to $360000.0 in 2025.
  • The last three reported values for Non Operating Income were $360000.0 (Q4 2025), -$269000.0 (Q3 2025), and -$385000.0 (Q2 2025) per Business Quant data.